Daniel Alkon

Company: Synaptogenix

Job title: President –Research

Seminars:

Uncovering Bryostatin Targets Restoration of Synaptic Wiring Lost in Alzheimer’s Degeneration 2:00 pm

Investigating actual cognitive improvement over baselines measured in initial placebo-controlled clinical trials Hearing evidence for sustained benefit for weeks after drug regimens have been in trialled Showcasing targets including synaptic growth factors, the apoptosis pathway, as well as amyloid and neurofibrillary tanglesRead more

day: Track B - Day 1 PM